Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Concierge MD LA vs Corsica Health

Concierge MD LA
Graded #328

Lower grade

vs+6.199999999999996
Corsica Health
Graded #188

Higher grade

The verdict

Corsica Health takes it — 66.3/100 to 60.1/100.

Corsica Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Corsica Health is a telehealth platform offering both compounded GLP-1s and brand-name FDA-approved injections through a structured assessment, provider review, and medication flow.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueCorsica Health +11
37
48
Dose & formulationConcierge MD LA +5
82
77
Clinical oversightCorsica Health +8
79
87
Labs & monitoringCorsica Health +1
53
54
FulfillmentCorsica Health +13
62
75
Contract termsCorsica Health +14
41
55
Concierge MD LA · left barCorsica Health · right bar

The numbers

MetricConcierge MD LACorsica Health
WeighScore60.1/10066.3/100
GradeCC
Scorecard rank#328#188
Semaglutide$1,999/mo (brand Ozempic)$249/mo (compounded)
Tirzepatide$299/mo (plus a separate fee, compounded)$349/mo (compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Concierge MD LA

Graded #328 · C

Strengths

  • Both compounded and brand-name GLP-1 options
  • In-home medical services in major cities
  • Competitive compounded pricing ($199/$299)
  • Broader concierge medicine services available

Where it loses points

  • No visible LegitScript or PCAB accreditation
  • No physical address disclosed
  • Limited to LA, NY, and 25+ cities — not nationwide
  • Brand-name options at $1,999/mo — very high
  • Semaglutide bills $199/mo but ships only every 90 days (tirzepatide every 60 days); 4-month minimum commitment required
Corsica Health

Graded #188 · C

Strengths

  • Public pricing shown for both compounded and brand-name options — a real transparency advantage
  • $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
  • LegitScript Certified
  • Clear 3-step intake: Assessment, Provider Review, Receive Medication
  • $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced

Where it loses points

  • Legal entity name and state of incorporation not disclosed on the site
  • Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
  • Per-state availability not listed publicly
  • First-month promotional pricing not disclosed
  • Lab-work inclusion not clearly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard